WHO ICTRP trial
Clinical trial comparing AXL1717 to docetaxel in patients with previously…
EUCTR2011-002007-15-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-002007-15-HU |
|---|---|
| Public title | Clinical trial comparing AXL1717 to docetaxel in patients with previously treated, locally advanced, or metastatic squamous cell carcinoma or adenocarcinoma of the lung |
| Scientific title | Phase II, randomized, open-label study of the IGF-1R inhibitor AXL1717 compared to docetaxel in patients with previously treated, locally advanced, or metastatic squamous cell carcinoma or adenocarcinoma of the lung |
| Primary sponsor | Axelar AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Belarus;Hungary;Poland;Ukraine;Russian Federation |
| Conditions | Non-small-cell lung cancer previously treated MedDRA version: 14.1 Level: LLT Classification code 10025054 Term: Lung cancer non-small cell stage IIIB System Organ Class: 100000004864 MedDRA version: 14.1 Level: LLT Classification code… |
| Interventions | Product Name: Picropodophyllin Product Code: AXL1717 Pharmaceutical Form: Oral suspension CAS Number: 477-47-4 Current Sponsor code: AXL1717 Other descriptive name: AXL1717(H2O), Picropodophyllin, BVT.51004G Concentration unit: mg/ml… |
| Registration date | Nov 8, 2011 |
| Target size | 140 |
| Secondary IDs | AXL-003 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: